State Street Corp raised its holdings in shares of Krystal Biotech, Inc. (NASDAQ:KRYS) by 8.2% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 712,997 shares of the company’s stock after purchasing an additional 54,039 shares during the period. State Street Corp owned 3.21% of […]